PEPD

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, PEPD mutation is significantly associated with the drug of many other genes, with 15 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible PEPD-associated genes across cancer lineages are 50869, 776928, and Ispinesib Mesylate. Each is linked with PEPD in more than 1 cancer types. Because this analysis shows association rather than direction, both PEPD-to-partner and partner-to-PEPD results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, 50869 grouped by PEPD-low versus PEPD-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (PEPD→partner) and Y-score (partner→PEPD) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINE50869 →+0.431+2.649.041.04631
LARGE_INTESTINE776928 →+0.696+2.710.027.02731
LARGE_INTESTINEIspinesib Mesylate →+0.668+2.652.041.04531
LARGE_INTESTINEGSK626616AC →+0.415+2.777.008.03812
LARGE_INTESTINEGallibiscoquinazole →+0.333+2.649.043.04621
LARGE_INTESTINEL-Oxonoreleagnine →+0.412+2.777.004.03821
Each partner links to its Q-omics profile. Showing the 6 strongest of 15 associations by consensus.

50869 by PEPD expression — LARGE_INTESTINE

Box plot of 50869 in PEPD-low vs PEPD-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration